Patent ID: 6440424
Filing Date: 2002-08-27
Classification: A61K,C07K,Y02A,Y10S

Abstract:
An immunogenic composition, comprising at least one active component selected from the group consisting of:(A) an isolated and purified outer membrane protein of a strain of Moraxella catarrhalis having a molecular mass of about 200 kDa, as determined by SDS-PAGE; and (B) a peptide consisting of the amino acid sequence NH2-Asn-Val-Lys-Ser-Val-Ile-Asn-Lys-Glu-Gln-Val-Asn-Asp-Ala-Asn-Lys-x-Gln-Gly-Ile (SEQ ID No: 2) or NH2-Asn-Val-Lys-Ser-Val-Ile-Asn-Lys-Glu-Gln-Val-Asn-Asp-Ala-Asn-Lys (SEQ ID No: 3); and a pharmaceutically acceptable carrier therefor, said at least one active component producing an immune response when administered to a host.